Finally, reducing the substrate of GCase in a mouse model of GBA PD through inhibition of glucosylceramide synthase reduced insoluble α-syn oligomerization and accumulation of ubiquitinated proteins (Sardi et al., 2017), providing compelling evidence that ameliorating altered lipid metabolism in PD can reduce the underlying pathology. The gene discussed is UGCG; the disease is Parkinson disease.